About this document

Uremia (End-Stage Renal Disease) by nathalie is a document available to read on EtoBox.

This article discusses the cost-effectiveness of strategies to prevent end-stage renal disease (ESRD). It finds that targeted screening for proteinuria in diabetics and hypertensive patients is cost-effective, but universal screening is not. Treatment of all newly diagnosed type 2 diabetics with drugs that inhibit angiotensin-II may also prevent ESRD in a cost-effective manner. Intensive interventions and use of these drugs in patients with diabetic or non-diabetic nephropathy can lower risks of ESRD cost-e

Author

nathalie

Language

EN